Fibroblastic reticular cells (FRCs) create T-cell-supportive niches within lung cancer tumors, facilitating T-cell migration, ...

November is Lung Cancer Awareness Month, which serves as a good reminder of the resources available locally to help catch the ...

Genprex has entered an exclusive licensing agreement with the US University of Michigan for lung cancer therapy, Reqorsa.

In recent decades, immunotherapy has transformed cancer treatment, offering effective options for diseases once considered ...

Researchers have unlocked a key in a person's immune response that could halt the spread of cancer the body cannot see.

Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...

Despite hotly debated biomarkers and failed or delayed confirmatory trials, the accelerated approval program has a track ...

This partnership will leverage Accenture’s generative AI studios to drive innovation in drug discovery, biomarker ...

One euro invested in diabetes prevention can save eight euros in the future. Diabetes is crushing Europe's health budgets, ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced it ...

HCG and Accenture collaborate on AI-driven cancer research and care, aiming to enhance precision medicine and patient ...

Murine Kras-driven lung cancer models have confirmed the key requirements for RAF, PI3K and RAL-GEF in vivo. Co-opted pathways required by oncogenic KRAS in order to sustain lung tumorigenesis ...